Aceto Claims That Aurobindo Caused Its Collapse

Aceto has blamed Aurobindo for its downfall, alleging a series of calculated and deceitful actions that have critically wounded the US group’s pharma business. Aurobindo has strongly denied the charges.

Boulder
ACETO CLAIMS AUROBINDO SABOTAGED ITS PLANS • Source: Shutterstock

US Aceto Corporation has accused the Indian company Aurobindo Pharma Ltd. of deploying a calculated and systematic scheme to destroy Aceto’s generic pharmaceutical business run through its subsidiary Rising Pharmaceuticals, forcing it out of the US generic market. The Indian group’s actions also allegedly contributed “substantially” to Aceto’s bankruptcy filing.

The case essentially revolves around Aceto’s 2016 acquisition of rights owned by Citron Pharma LLC and its affiliate Lucid Pharma...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Business

More from Generics Bulletin